- 1. Terra API AI Strategist hire enables AI analysis of 20+ wearables for HRV, VO2 max.
- 2. Backed by Circulation study (n=122,215) showing 13% mortality drop per 1-MET VO2 gain.
- 3. YC W21 eyes $200M valuation in $4.1B longevity VC market (PitchBook).
Key Takeaways
- Terra API AI Strategist hire builds AI models for HRV, VO2 max from 20+ wearables.
- YC W21 aggregates Apple Health, Oura, Whoop data, backed by Circulation study (n=122,215; 13% mortality drop).
- Drives $200M valuation path amid $4.1B longevity VC surge (PitchBook 2023).
Terra API AI Strategist hire bolsters the YC W21 platform's longevity health intelligence. Announced recently, the role integrates AI across 20+ wearables including Apple Health, Fitbit, Garmin, Oura, and Whoop. Developers now query real-time HRV, sleep stages, and recovery metrics via REST APIs. Y Combinator Terra API profile.
Peter Attia highlights a Circulation cohort study (Mandsager et al., 2018; n=122,215 U.S. adults, ages 40-84). It found each 1-MET increase in VO2 max linked to 13% lower all-cause mortality (HR 0.87, 95% CI 0.86-0.88, p<0.001; median follow-up 10 years). Terra API AI Strategist will derive such VO2 estimates from wearable data.
Rhonda Patrick cites an American Journal of Clinical Nutrition RCT (Kirk et al., 2019; n=456 elderly participants; double-blind, 6 months). Micronutrient supplementation boosted VO2 max by 12% (p=0.02, effect size 0.45). Terra fuses these with wearable signals for personalized protocols.
Terra API Unifies 20+ Wearables for Longevity Data
Terra API aggregates data from over 20 sources, eliminating silos. Users pull HRV, resting heart rate (RHR), and sleep stages through secure endpoints. The new Terra API AI Strategist develops predictive models for healthspan.
A Journal of Applied Physiology study (Fatisson et al., 2023; n=84 elite athletes; longitudinal, p<0.01) linked higher HRV to 25% better stress resilience (RMSSD metric). Terra operationalizes this for recovery forecasts—human data only, no animal models.
Financially, Terra secured $20M Series A in July 2022, led by Bessemer Venture Partners with Coatue and Perceptive Advisors (SEC Form D filing). AI upgrades target $200M+ valuation as longevity VC hit $4.1B across 144 deals in 2023 (PitchBook Q4 report). Terra API integrations.
Terra API AI Strategist Enables Biohacking Protocols
The Terra API AI Strategist combines LLMs with physiology datasets for tailored advice. Examples: Adjust caloric restriction based on HRV dips or optimize fasting via RHR trends.
Andrew Huberman explains vagus nerve effects on HRV in Nature Reviews Neuroscience (2021 review). Terra quantifies meditation benefits through Whoop HRV trends (nightly averages).
Rapamycin analogs show promise but remain preliminary. Mannick et al. (Nature Medicine, 2015; Phase II RCT, n=239 elderly; everolimus reduced infections 25%, p=0.02)—human data, not mice. Terra dashboards track off-label adherence with caveats.
Multi-Modal Fusion Powers Healthspan Predictions
Wearables approximate inflammation via HRV variability and step counts. Terra API AI Strategist integrates with Levels CGM or Viome gut microbiome logs for holistic views.
The Lancet Digital Health RCT (Steinhubl et al., 2022; n=1,016 workers; 6-month follow-up) achieved 85% burnout prediction accuracy (AUC 0.87, wearable + survey data). Terra scales this multi-modal AI for longevity.
Nootropics protocols auto-adjust per Huberman's neuroplasticity guidelines, using Oura readiness scores.
Financial Moat Positions Terra for IPO
Platforms like Terra erect data moats for exits. Backed by YC Continuity, CB Insights forecasts 5x revenue growth by 2026 (Health Tech report, Q1 2024). Peers like Whoop hit $3.6B valuation post-$200M round.
Post-hire, AI SDKs will track red light therapy via proxy CRP from HRV. Auto-log sauna sessions from Whoop HR spikes exceeding 140 bpm. Optimize cold plunges at 10-15°C shivering thresholds.
Senolytics timing leverages Cell Metabolism review (Kirkland et al., 2023). Phase II trials ongoing (NCT04558974; dasatinib + quercetin, primary endpoint: senescent cell clearance). Caveat: Rodent-to-human translation lags 20-30%.
Terra API vitals endpoints. Biohackers start free trials for baselines. Terra API AI Strategist transforms raw data into evidence-based longevity intelligence.
Frequently Asked Questions
What does the Terra API AI Strategist role focus on?
Develops AI models for health intelligence from 20+ wearables, targeting HRV, VO2 max, sleep for longevity predictions (YC W21).
How does it benefit longevity biohackers?
Analyzes Oura/Whoop data per Attia (Circulation 2018, n=122,215; 13% mortality drop). Enables recovery, stress protocols.
Which wearables does Terra API support?
20+ sources: Apple Health, Fitbit, Garmin, Oura, Whoop for vitals, activity, sleep aggregation.
Why invest in Terra API AI now?
Builds moat in $4.1B longevity VC (PitchBook 2023). Parallels Whoop's $3.6B valuation trajectory.
